▲ Peaking
Business
Hospital and pharmaceutical prices are smothering America’s businesses
Rising hospital and pharmaceutical costs are creating significant financial pressure for American businesses and patients alike.
Stat
19 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
CDC updates measles toll, now counts 2 deaths
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Pharma's new top lobbyist is a former House majority leader
Eric Cantor, the former House majority leader, has been selected as the new president and chief executive officer of PhRMA.
◼ Archived
Business
UniQure’s gene therapy continues to slow Huntington’s progression after four years
UniQure shares tumble significantly as clinical trial data for its Huntington’s gene therapy draws conflicting reports.
◼ Archived
Health
Scientists are finally starting to figure out Alzheimer’s
Recent breakthroughs in immunology and new pharmaceutical frontiers are shifting the approach to treating Alzheimer's disease.
◼ Archived
Health
Doctors in Pennsylvania estimate at least six babies have been born with measles
Controversy grows over measles death statistics as RFK Jr. utilizes data from the National Center for Health Statistics.
◼ Archived
Health
Trump calls for some childhood vaccines be split into smaller doses
President Trump has called for certain childhood vaccines to be split into smaller doses, according to recent media reports.
◼ Archived
Health
🔮 fades ✗
Scientists boycott American Diabetes Association as fallout of June conference fracas escalates
Scientists and journal editors have launched a boycott of the American Diabetes Association following a June conference incident.
◼ Archived
Health
🔮 fades ✓
From algorithms to patient outcomes — lessons from one of the first randomized trials of AI in medicine
Early randomized trials and industry leadership suggest a complex reality for AI's integration into emergency medicine and clinical practice.
◼ Archived
Business
🔮 fades ✓
Novartis stock slides as centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test
Novartis shares experienced their worst single-day drop in over two decades following the failure of a crucial phase 3 trial for an Avidity buyout drug.
◼ Archived
Health
🔮 fades ✗
New Migraine Prevention Guidelines Released
Updated US clinical guidelines expand pharmacologic treatment options and eligibility for adult migraine prevention.
◼ Archived
Sports
🔮 fades ✓
2026 NFL rookies guide: Stat leaders, fantasy picks, top QBs
Fantasy football experts and predictive models are releasing 2026 draft guides, highlighting breakout stars and must-have rookie talent.
◼ Archived
Business
🔮 fades ✓
Trump unveils more prescription drug pricing discounts projected to save Americans $600B: 'Major step forward'
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
What it was like to go through a trial that could revolutionize cancer treatment
Moderna and Merck have reported a significant triumph regarding a collaborative cancer vaccine trial that could revolutionize oncology treatment.
◼ Archived
Health
🔮 fades ✗
Is Protein Maxxing Backfiring? What a Major New Study Reveals About Aging
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
AI has created a shadow medical system
Reports indicate the emergence of a 'shadow medical system' as AI integration outpaces official healthcare policy and professional medical roles.
◼ Archived
Health
🔮 fades ✓
Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T
Coverage reveals a third death in opaque Chinese clinical trials involving CAR-T therapy, intensifying global scrutiny.
◼ Archived
Business
🔮 fades ✓
We proved bipartisan health care reform works in North Carolina. Let’s bring it nationwide
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Merck is establishing global access and licensing frameworks for the world's first monthly oral HIV prevention pill ahead of its official approval.